On one hand, these therapies are helping to destigmatize obesity by emphasizing its biological underpinnings and offering an effective, evidence-based medical intervention.[172] On the other hand, their growing use for cosmetic or lifestyle purposes, particularly among public figures and celebrities, risks reframing obesity drugs as luxury wellness products rather than critical clinical tools for managing chronic disease.[173] This blurring of clinical necessity and aesthetic demand may undermine public understanding of the serious health risks associated with obesity and detract from the therapeutic value GLP-1s offer to medically at-risk populations.[174] It is therefore critical that public and policy discourse clearly center these medications within the context of metabolic and chronic disease management
GoodRx is not sponsored by or affiliated with any of the third-party brands identified
[DOI] [PMC free article] [PubMed] [Google Scholar] 152.Korbut A.I., Taskaeva I.S., Bgatova N.P., Muraleva N.A., Orlov N.B., Dashkin M.V., Khotskina A.S., Zavyalov E.L., Konenkov V.I., Klein T., et al
Connective Tissue: Histology, elastic Elastic Connective Tissue: Histology fibers, fibroblasts Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules
Blood 119, 52765284
The secret sauce is not AI Even as the story of Medvi has created a huge buzz in tech circles there are two aspects of it that are giving people pause
